GlaxoSmithKline
GSK
#220
Rank
HK$736.74 B
Marketcap
HK$366.72
Share price
-1.14%
Change (1 day)
45.99%
Change (1 year)

Market capitalization of GlaxoSmithKline (GSK)

Market cap: HK$736.74 Billion

As of November 2025 GlaxoSmithKline has a market cap of HK$736.74 Billion. This makes GlaxoSmithKline the world's 220th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GlaxoSmithKline from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$736.74 B36.48%
2024HK$539.81 B-9.36%
2023HK$595.52 B5.96%
2022HK$562.04 B-33.94%
2021HK$850.76 B19.59%
2020HK$711.37 B-21.52%
2019HK$906.42 B23.22%
2018HK$735.60 B6.85%
2017HK$688.46 B-5.77%
2016HK$730.64 B-4.83%
2015HK$767.75 B-4.98%
2014HK$807.96 B-19.23%
2013HK$1.000 T22.02%
2012HK$819.82 B-8.37%
2011HK$894.70 B12.83%
2010HK$792.99 B-6.73%
2009HK$850.25 B13.83%
2008HK$746.95 B-30.97%
2007HK$1.082 T-8.37%
2006HK$1.180 T3.36%
2005HK$1.142 T4.5%
2004HK$1.093 T7.11%
2003HK$1.020 T16%
2002HK$879.93 B-26.61%
2001HK$1.199 T-12.73%
2000HK$1.373 T73.87%
1999HK$790.20 B-19.05%
1998HK$976.14 B47.2%
1997HK$663.14 B52.32%
1996HK$435.35 B

End of Day market cap according to different sources

On Nov 15th, 2025 the market cap of GlaxoSmithKline was reported to be:

HK$746.13 Billion
by Nasdaq info icon info icon
HK$736.74 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
HK$2.154 T 192.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$1.107 T 50.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$1.792 T 143.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$1.966 T 166.94%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$987.23 B 34.00%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
HK$233.85 B-68.26%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
HK$10.09 B-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA